Success Metrics

Clinical Success Rate
89.7%

Based on 26 completed trials

Completion Rate
90%(26/29)
Active Trials
0(0%)
Results Posted
15%(4 trials)
Terminated
3(9%)

Phase Distribution

Ph phase_2
1
3%
Ph phase_1
1
3%
Ph phase_3
13
39%
Ph not_applicable
9
27%
Ph phase_4
9
27%

Phase Distribution

1

Early Stage

1

Mid Stage

22

Late Stage

Phase Distribution33 total trials
Phase 1Safety & dosage
1(3.0%)
Phase 2Efficacy & side effects
1(3.0%)
Phase 3Large-scale testing
13(39.4%)
Phase 4Post-market surveillance
9(27.3%)
N/ANon-phased studies
9(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.9%

26 of 31 finished

Non-Completion Rate

16.1%

5 ended early

Currently Active

0

trials recruiting

Total Trials

33

all time

Status Distribution
Completed(26)
Terminated(5)
Other(2)

Detailed Status

Completed26
Terminated3
Withdrawn2
Suspended1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
33
Active
0
Success Rate
89.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (3.0%)
Phase 21 (3.0%)
Phase 313 (39.4%)
Phase 49 (27.3%)
N/A9 (27.3%)

Trials by Status

completed2679%
suspended13%
terminated39%
unknown13%
withdrawn26%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT04280692Phase 1

Controlled Human Malaria Infection Transmission Model - Phase A

Suspended
NCT00852371Phase 3

Intermittent Preventive Treatment of Malaria in Schoolchildren

Completed
NCT00000727Phase 3

A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)

Completed
NCT03009526Phase 3

Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi

Completed
NCT00299247Phase 3

SP Resistance and Falciparum Malaria Transmission

Withdrawn
NCT00203801Not Applicable

Combination Antimalarials in Uncomplicated Malaria

Completed
NCT00857077Not Applicable

Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana

Completed
NCT00361114Phase 3

IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.

Terminated
NCT00120809Phase 3

Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae

Completed
NCT00131716Phase 3

Prevention of Severe Anaemia in Gambian Children

Completed
NCT01443130Phase 3

Chloroquine for Malaria in Pregnancy

Completed
NCT00323622Phase 2

Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine

Completed
NCT02351687Not Applicable

Package of Interventions After Recovering From Moderate Acute Malnutrition

Completed
NCT00380146Not Applicable

Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women

Completed
NCT00711906Phase 3

Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy

Terminated
NCT02575755Phase 4

A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women

Unknown
NCT01103063Phase 3

Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa

Terminated
NCT01184911Phase 4

Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda

Withdrawn
NCT01722539Phase 3

Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren

Completed
NCT00167843Phase 4

Reducing the Effects of Malaria in Children by Administering Repeated Preventive Doses

Completed

Drug Details

Intervention Type
DRUG
Total Trials
33